European Union -
Estonian -
EMA (European Medicines Agency)
arsenic trioxide medac
medac gesellschaft für klinische spezialpräparate mbh - arseentrioksiid - leukeemia, promüelotsüütne, äge - antineoplastilised ained - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene. vastuse määr muude ägeda müeloidse leukeemia alatüüpi, et arseentrioksiid ei ole uuritud.
European Union -
Estonian -
EMA (European Medicines Agency)
rezolsta
janssen-cilag international n.v. - darunavir, cobicistat - hiv-nakkused - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta on näidustatud koos teiste retroviirusevastaste ravimitega inimese immuunpuudulikkuse viiruse 1 (hiv 1) nakkuse raviks 18-aastastel ja vanematel täiskasvanutel. genotypic katsetamine peaks juhendi kasutamine rezolsta.
European Union -
Estonian -
EMA (European Medicines Agency)
orserdu
stemline therapeutics b.v. - elacestrant - rinnanäärmed - endokriinset ravi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
Estonia -
Estonian -
Ravimiamet
nutrineal pd4 clear-flex peritoneaaldialüüsilahus
oÜ baxter estonia - aminohapped+naatriumkloriid+kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+naatriumlaktaat - peritoneaaldialüüsilahus - 11,2g+5,38g+0,184g+0,051g+4,48g 1l 2l 4tk
Estonia -
Estonian -
Ravimiamet
ranolazine elc toimeainet prolongeeritult vabastav tablett
elc group s.r.o. - ranolasiin - toimeainet prolongeeritult vabastav tablett - 375mg 100tk; 375mg 30tk